FON-2021-1250 - IFG.pdf (1.41 MB)
Download fileInfographic – Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: Phase II PHAROS study design
figure
posted on 2022-01-31, 09:00 authored by Figshare Future Science GroupFigshare Future Science Group, Gregory J Riely, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Egbert F Smit, Anne S Tsao, Ann Alcasid, Tiziana Usari, Paul S Wissel, Keith D Wilner, Bruce E JohnsonEncorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: Phase II PHAROS study design
Infographic – Summary of the article
